Position history for Candriam S.C.A.'s holdings in ALNYLAM PHARMACEUTICALS INC
Candriam S.C.A. holds 224,330 shares of ALNY (ALNYLAM PHARMACEUTICALS INC), worth $74.2M as of 2026-Q1. ALNY represents 0.4% of Candriam S.C.A.'s portfolio.
Current Value
$74.2M
Current Shares
224,330
Total Value Change
-$11.1M
Total Shares Change
-126,898
Other major holders of ALNY: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Unchanged |
| 224,330 |
0.0% |
| $74.2M |
| 0.4% |
| $318.65 |
0 |
| 2025-Q4 | Increased | 224,330 | +5.6% | $89.2M | 0.4% | $397.25 | 38 |
| 2025-Q3 | Decreased | 212,416 | -10.8% | $96.9M | 0.5% | $447.49 | 0 |
| 2025-Q2 | Decreased | 238,084 | -4.7% | $77.6M | 0.4% | $322.83 | 0 |
| 2025-Q1 | Decreased | 249,919 | -11.5% | $67.5M | 0.4% | $268.46 | 0 |
| 2024-Q4 | Decreased | 282,407 | -19.7% | $66.5M | 0.4% | $236.01 | 0 |
| 2024-Q3 | Increased | 351,668 | +0.1% | $96.7M | 0.6% | $274.91 | 42 |
| 2024-Q2 | Increased | 351,228 | +10.8% | $85.3M | 0.5% | $243.00 | 47 |